PLGA, PLGA-TMC and TMC-TPP Nanoparticles Differentially Modulate the Outcome of Nasal Vaccination by Inducing Tolerance or Enhancing Humoral Immunity

Open Access

Peer-reviewed

Research Article

Chantal Keijzer,

Affiliation Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands
⨯
Bram Slütter,

Affiliation Division of Drug Delivery Technology, Leiden/Amsterdam Center for Drug Research (LACDR), Leiden, The Netherlands
⨯
Ruurd van der Zee,

Affiliation Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands
⨯
Wim Jiskoot,

Affiliation Division of Drug Delivery Technology, Leiden/Amsterdam Center for Drug Research (LACDR), Leiden, The Netherlands
⨯
Willem van Eden,

Affiliation Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands
⨯
Femke Broere

* E-mail: f.broere@uu.nl

Affiliation Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands
⨯

Reader Comments (0)

Nanoparticles
Is the Subject Area "Nanoparticles" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Antigen encapsulation
Is the Subject Area "Antigen encapsulation" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
Arthritis
Is the Subject Area "Arthritis" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
B cells
Is the Subject Area "B cells" applicable to this article?

Thanks for your feedback.
Humoral immunity
Is the Subject Area "Humoral immunity" applicable to this article?

Thanks for your feedback.